Noninvasive prenatal screening for genetic diseases using massively parallel sequencing of maternal plasma DNA

Cold Spring Harbor Perspectives in Medicine

Volumn 5, Issue 9, 2015, Pages

  Chitty, Lyn S ^a,b,c   Lo, Y M Dennis ^d,e  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^e CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CELL FREE FETAL DNA; DNA; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ANEUPLOIDY; ARTICLE; DNA METHYLATION; DNA SEQUENCE; GENETIC DISORDER; HUMAN; MATERNAL PLASMA; MOLECULAR DIAGNOSIS; MONOGENIC DISORDER; NEXT GENERATION SEQUENCING; NON INVASIVE PROCEDURE; PRENATAL SCREENING; SCREENING TEST; ATTITUDE TO HEALTH; BLOOD; CELL FREE SYSTEM; ECONOMICS; FEMALE; GENE EXPRESSION PROFILING; GENETIC DISEASES, INBORN; GENETIC SCREENING; GENETICS; HEALTH PERSONNEL ATTITUDE; PATENT; PHYSIOLOGY; PLASMA; PREGNANCY; PRENATAL DIAGNOSIS; PROCEDURES;

ANEUPLOIDY; ATTITUDE OF HEALTH PERSONNEL; ATTITUDE TO HEALTH; CELL-FREE SYSTEM; DNA; DNA METHYLATION; FEMALE; GENE EXPRESSION PROFILING; GENETIC DISEASES, INBORN; GENETIC TESTING; HUMANS; INTELLECTUAL PROPERTY; PLASMA; PREGNANCY; PRENATAL DIAGNOSIS; SEQUENCE ANALYSIS, DNA;

EID: 84940763492     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a023085     Document Type: Article

References (126)

1. ACOG Committee Opinion 545. 2012. Noninvasive prenatal testing for fetal aneuploidy.Obstet Gynecol 120: 1532–1534.
2. Agarwal A, Sayres LC, Cho MK, Cook-Deegan R, Chandrasekharan S. 2013. Commercial landscape of non-invasive prenatal testing in the United States. Prenat Diagn 33: 521–531.
3. Alberry M, Maddocks D, Jones M, Abdel Hadi M, Abdel-Fattah S, Avent N, Soothill P. 2007. Free fetal DNA in maternal plasma in anembryonic pregnancies: Confirmation that the origin is the trophoblast. Prenat Diagn 27: 415–418.
4. Allyse M, Sayres LC, Goodspeed TA, Cho MK. 2014. Attitudes towards non-invasive prenatal testing for aneuploidy among US adults of reproductive age. J Perinatol 34: 429–434.
5. Amicucci P, Gennarelli M, Novelli G, Dallapiccola B. 2000. Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma. Clin Chem 46: 301–302.
6. Ashoor G, Syngelaki A, Wang E, Struble C, Oliphant A, Song K, Nicolaides KH. 2013. Trisomy 13 detection in the first trimester of pregnancy using a chromosome-selective cell-free DNA analysis method. Ultrasound Obstet Gynecol 41: 21–25.
7. Barrett AN, McDonnell TC, Chan KC, Chitty LS. 2012. Digital PCR analysis of maternal plasma for non-invasive detection of sickle cell anemia. Clin Chem 58: 1026–1032.
8. Benn P, Borrell A, Crossley J, Cuckle H, Dugoff L, Gross S, Johnson JA, Maymon R, Odibo A, Schielen P, et al. 2011. Aneuploidy screening: A position statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, January 2011. Prenat Diagn 31: 519–522.
9. Beulen L, Grutters JP, Faas BH, Feenstra I, van Vugt JM, Bekker MN. 2014. The consequences of implementing non-invasive prenatal testing in Dutch national health care: A cost-effectiveness analysis. Eur J Obstet Gynecol Reprod Biol 182: 53–61.
10. Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA. 1996. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci 93: 705–708.
11. Bianchi DW, Platt LD, Goldberg JD, Abuhamad AZ, Sehnert AJ, Rava RP; MatErnal Blood IS Source to Accurately diagnose fetal aneuploidy (MELISSA Study Group). 2012. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 119: 890–901.
12. Bianchi DW, Parker RL, Wentworth J, Madankumar R, Saffer C, Das AF, Craig JA, Chudova DI, Devers PL, Jones KW, et al. 2014. DNA sequencing versus standard prenatal aneuploidy screening. N Engl J Med 370: 799–808.
13. Boon EM, Faas BH. 2013. Benefits and limitations of whole genome versus targeted approaches for non-invasive prenatal testing for fetal aneuploidies. Prenat Diagn 33: 563–568.
14. Canick JA, Kloza EM, Lambert-Messerlian GM, Haddow JE, Ehrich M, van den Boom D, Bombard AT, Deciu C, Palomaki GE. 2012. DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations. Prenat Diagn 32: 730–734.
15. Chan KCA, Zhang J, Hui AB, Wong N, Lau TK, Leung TN, Lo KW, Huang DW, Lo YMD. 2004. Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem 50: 88–92.
16. Chan KC, Jiang P, Chan CW, Sun K, Wong J, Hui EP, Chan SL, Chan WC, Hui DS, Ng SS, et al. 2013. Non-invasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing. Proc Natl Acad Sci 110: 18761–18768.
17. Chandrasekharan S, Minear MA, Hung A, Allyse M. 2014. Non-invasive prenatal testing goes global. Sci Transl Med 6: 231–235.
18. Chen EZ, Chiu RW, Sun H, Akolekar R, Chan KC, Leung TY, Jiang P, Zheng YW, Lun FM, Chan LY, et al. 2011. Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasmaDNA sequencing. PLoS One 6: e21791.
19. Chen S, Ge H, Wang X, Pan X, Yao X, Li X, Zhang C, Chen F, Jiang F, Li P, et al. 2013. Haplotype-assisted accurate noninvasive fetal whole genome recovery through maternal plasma sequencing. Genome Med 5: 18.
20. Chetty S, Garabedian MJ, Norton ME. 2013.Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening. Prenat Diagn 33: 542–546.
21. Chim SSC, Tong YK, Chiu RWK, Lau TK, Leung TN, Chan LYS, Oudejans CBM, Ding C, Lo YMD. 2005. Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proc Natl Acad Sci 102: 14753–14758.
22. Chitty LS, Bianchi DW. 2013. Non-invasive prenatal testing: The paradigm is shifting rapidly. Prenat Diagn 33: 511–513.
23. Chitty LS, Griffin DR, Meaney C, Barrett A, Khalil A, Pajkrt E, Cole TJ. 2011. New aids for the non-invasive prenatal diagnosis of achondroplasia: Dysmorphic features, charts of fetal size and molecular confirmation using cell-free fetalDNA in maternal plasma. UltrasoundObstet Gynecol 37: 283–289.
24. Chitty LS, Chatelain P, Wolffenbuttel KP, Aigrain Y. 2012a. Prenatal management of disorders of sex development. J Pediat Urol 8: 576–584.
25. Chitty LS, Hill M, White H, Wright D, Morris S. 2012b. Non-invasive prenatal testing for aneuploidy-ready for prime time? Am J Obstet Gynecol 206: 269–275.
26. Chitty LS, Khalil A, Barrett AN, Pajkrt E, Griffin DR, Cole T. 2013. Safer, accurate prenatal diagnosis of thanatophoric dysplasia using ultrasound and cell free fetalDNA. Prenat Diagn 33: 416–423.
27. Chitty LS, Mason S, Barrett AB, McKay F, Lench N, Daley R, Jenkins LA. 2015. Non-invasive prenatal diagnosis of achondroplasia and thanatophoric dysplasia: Next generation sequencing allows for a safer, more accurate and comprehensive approach. Prenat Diagn 35.
28. Chiu RW, Lau TK, Leung TN, Chow KC, Chui DH, Lo YM. 2002. Prenatal exclusion of b thalassaemia major by examination of maternal plasma. Lancet 360: 998–1000.
29. Chiu RW, Chan KC, Gao Y, Lau VY, Zheng W, Leung TY, Foo CH, Xie B, Tsui NB, Lun FM, et al. 2008. Non-invasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci 105: 20458–20463.
30. Chiu RW, Akolekar R, Zheng YW, Leung TY, Sun H, Chan KC, Lun FM, Go AT, Lau ET, To WW, et al. 2011. Noninvasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: Large scale validity study. BMJ 342: c7401.
31. Choi H, Lau TK, Jiang FM, Chan MK, Zhang HY, Lo PS, Chen F, Zhang L, Wang W. 2013. Fetal aneuploidy screening by maternal plasma DNA sequencing: ‘false positive’ due to confined placental mosaicism. Prenat Diagn 33: 198–200.
32. Clausen FB, Christiansen M, Steffensen R, Jørgensen S, Nielsen C, Jakobsen MA, Madsen RD, Jensen K, Krog GR, Rieneck K, et al. 2012. Report of the first nationally implemented clinical routine screening for fetal RHD in D- pregnant women to ascertain the requirement for antenatal RhD prophylaxis. Transfusion 52: 752–758.
33. Costa JM, Benachi A, Gautier E. 2002. New strategy for prenatal diagnosis of X-linked disorders. N Engl J Med 346: 1502.
34. Cuckle H, Benn P, Pergament E. 2013. Maternal cfDNA screening for Down syndrome—A cost sensitivity analysis. Prenat Diagn 33: 636–642.
35. Dan S, Wang W, Ren J, Li Y, Hu H, Xu Z, Lau TK, Xie J, Zhao W, Huang H, et al. 2012. Clinical application of massively parallel sequencing-based prenatal non-invasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors. Prenat Diagn 32: 1225–1232.
36. Dar P, Curnow KJ, Gross SJ, Hall MP, Stosic M, Demko Z, Zimmermann B, Hill M, Sigurjonsson S, Ryan A, et al. 2014. Clinical experience and follow-up with large scale single-nucleotide polymorphism-based non-invasive prenatal aneuploidy testing. Am J Obstet Gynecol 211: 527.e1–527.e17.
37. de Haas M, van der Ploeg CPB, Scheffer PG, Verlinden DA, Hirschberg H, Abbink F, van der Schoot CE. 2012. A nationwide fetal RHD screening programme for targeted antenatal and postnatal anti-D. ISBT Science Series 7: 164–167.
38. del Mar Gil M, Quezada MS, Bregant B, Syngelaki A, Nicolaides KH. 2014. Cell-free DNA analysis for trisomy risk assessment in first-trimester twin pregnancies. Fetal Diagn Ther 35: 204–211.
39. Devers PL, Cronister A, Ormond KE, Facio F, Brasington CK, Flodman P. 2013. Non-invasive prenatal testing/non-invasive prenatal diagnosis: The position of the National Society of Genetic Counselors. J Genet Couns 22: 291–295.
40. Ehrich M, Deciu C, Zwiefelhofer T, Tynan JA, Cagasan L, Tim R, Lu V, McCullough R, McCarthy E, Nygren AO, Dean J, et al. 2011. Non-invasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: A study in a clinical setting. Am J Obstet Gynecol 204: 205.201–211.
41. Faas BH, Beuling EA, Christiaens GC, von dem Borne AE, van der Schoot CE. 1998. Detection of fetal RHD-specific sequences in maternal plasma. Lancet 352: 1196.
42. Fan HC, Quake SR. 2007. Detection of aneuploidy with digital polymerase chain reaction. Anal Chem 79: 7576–7579.
43. Fan HC, Blumenfeld YJ, Chitkara U, Hudgins L, Quake SR. 2008.Non-invasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci 105: 16266–16271.
44. Fan HC, Gu W, Wang J, Blumenfeld YJ, El-Sayed YY, Quake SR. 2012.Non-invasive prenatal measurement of the fetal genome. Nature 487: 320–324.
45. Finning KM, Martin PG, Soothill PW, Avent ND. 2002. Prediction of fetal D status from maternal plasma: Introduction of a new non-invasive fetal RHD genotyping service. Transfusion 42: 1079–1085.
46. Finning K, Martin P, Summers J, Daniels G. 2007. Fetal genotyping for the K (Kell) and Rh C, c, and E blood groups on cell-free fetal DNA in maternal plasma. Transfusion 47: 2126–2133.
47. Futch T, Spinosa J, Bhatt S, de Feo E, Rava RP, Sehnert AJ. 2013. Initial clinical laboratory experience in non-invasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples. Prenat Diagn 33: 569–574.
48. Gil MM, Akolekar R, Quezada MS, Bregant B, Nicolaides KH. 2014. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: Meta-analysis. Fetal Diagn Ther 35: 156–173.
49. Goetzinger KR, Odibo AO. 2014. Screening for abnormal placentation and adverse pregnancy outcomes with maternal serum biomarkers in the second trimester. Prenat Diagn 34: 635–641.
50. Gonzalez-Gonzalez MC, Garcia-Hoyos M, Trujillo MJ, Rodriguez de Alba M, Lorda-Sanchez I, Diaz-Recasens J, Gallardo E, Ayuso C, Ramos C. 2002. Prenatal detection of a cystic fibrosis mutation in fetal DNA from maternal plasma. Prenat Diagn 22: 946–948.
51. Gregg AR, Gross SJ, Best RG, Monaghan KG, Bajaj K, Skotko BG, Thompson BH, Watson MS. 2013. ACMG statement on non-invasive prenatal screening for fetal aneuploidy. Genet Med 15: 395–398.
52. Hayden EC. 2012. Fetal tests spur legal battle: A newborn industry based on non-invasive genetic testing turns combative. Nature 486: 454.
53. Hill M, Finning K, Martin P, Hogg J, Meaney C, Norbury G, Daniels G, Chitty LS. 2011. Non-invasive prenatal determination of fetal sex: Translating research into clinical practice. Clin Genet 80: 68–75.
54. Hill M, Fisher J, Chitty LS, Morris S. 2012a. Women’s and health professionals’ preferences for prenatal tests for Down syndrome: A discrete choice experiment to contrast non-invasive prenatal diagnosis with current invasive tests. Genet Med 14: 905–913.
55. Hill M, Lewis C, Jenkins L, Allen S, Elles RG, Chitty LS. 2012b. Implementing non-invasive prenatal fetal sex determination using cell-free fetalDNA in theUnited Kingdom. Expert Opin Biol Ther 12: S119–S126.
56. Hill M, Wright D, Daley R, Lewis C, McKay F, Mason S, Lench N, Howarth A, Boustred C, Lo K, et al. 2014. Evaluation of non-invasive prenatal testing (NIPT) for aneuploidy in an NHS setting: A reliable accurate prenatal non-invasive diagnosis (RAPID) protocol. BMC Pregnancy Childbirth 14: 229–238.
57. Hill M, Twiss P, Verhoef T, Drury S, McKay F, Mason S, Jenkins L, Morris S, Chitty LS. 2015. Non-invasive prenatal diagnosis for cystic fibrosis: Detection of paternal mutations, exploration of patient preferences and cost analysis. Prenat Diagn 35.
58. Hooks J, Wolfberg AJ, Wang ET, Struble CA, Zahn J, Juneau K, Mohseni M, Huang S, Bogard P, Song K, et al. 2014. Non-invasive risk assessment of fetal sex chromosome aneuploidy through directed analysis and incorporation of fetal fraction. Prenat Diagn 34: 496–499.
59. Huang X, Zheng J, Chen M, Zhao Y, Zhang C, Liu L, Xie W, Shi S, Wei Y, Lei D, et al. 2014. Non-invasive prenatal testing of trisomies 21 and 18 by massively parallel sequencing of maternal plasma DNA in twin pregnancies. Prenat Diagn 34: 335–340.
60. Hudecova I, Sahota D, Heung MM, Jin Y, Lee WS, Leung TY, Lo YM, Chiu RW. 2014.Maternal plasma fetal DNA fractions in pregnancies with low and high risks for fetal chromosomal aneuploidies. PLoS ONE 28: e88484.
61. Hyett JA, Gardener G, Stojilkovic-Mikic T, Finning KM, Martin PG, Rodeck CH, Chitty LS. 2005. Reduction in diagnostic and therapeutic interventions by non-invasive determination of fetal sex in early pregnancy. Prenat Diagn 25: 1111–1116.
62. Jensen TJ, Dzakula Z, Deciu C, van den Boom D, Ehrich M. 2012. Detection of microdeletion 22q11.2 in a fetus by next-generation sequencing of maternal plasma. Clin Chem 58: 1148–1151.
63. Juneau K, Bogard PE, Huang S, Mohseni M, Wang ET, Ryvkin P, Kingsley C, Struble CA, Oliphant A, Zahn JM. 2014. Microarray-based cell-free DNA analysis improves noninvasive prenatal testing. Fetal Diagn Ther 36: 282–286.
64. Kitzman JO, Snyder MW, Ventura M, Lewis AP, Qiu R, Simmons LE, Gammill HS, Rubens CE, Santillan DA, Murray JC, et al. 2012. Non-invasive whole-genome sequencing of a human fetus. Sci Transl Med 4: 137-176.
65. Koh W, Pan W, Gawad C, Fan HC, Kerchner GA, Wyss-Coray T, Blumenfeld YJ, El-Sayed YY, Quake SR. 2014. Noninvasive in vivo monitoring of tissue-specific global gene expression in humans. Proc Natl Acad Sci 111: 7361–7366.
66. Lam KW, Jiang P, Liao GJ, Chan KC, Leung TY, Chiu RW, Lo YMD. 2012. Non-invasive prenatal diagnosis of monogenic diseases by targeted massively parallel sequencing of maternal plasma: Application to b-thalassemia. Clin Chem 58: 1467–1475.
67. Larion S, Warsof SL, Romary L, Mlynarczyk M, Peleg D, Abuhamad AZ. 2014a. Association of combined first-trimester screen and non-invasive prenatal testing on diagnostic procedures. Obstet Gynecol 123: 1303–1310.
68. Larion S, Warsof SL, Romary L, Mlynarczyk M, Peleg D, Abuhamad AZ. 2014b. Uptake of non-invasive prenatal testing at a large academic referral center. Am J Obstet Gynecol 211: 651–651.
69. Lau TK, Jiang F, Chan MK, Zhang H, Lo PS, Wang W. 2012. Non-invasive prenatal screening of fetal Down syndrome by maternal plasma DNA sequencing in twin pregnancies. J Matern Fetal Neonatal Med 26: 434–437.
70. Lau TK, Jiang FM, Stevenson RJ, Lo TK, Chan LW, Chan MK, Lo PS, Wang W, Zhang HY, Chen F, et al. 2013. Secondary findings from non-invasive prenatal testing for common fetal aneuploidies by whole genome sequencing as a clinical service. Prenat Diagn 33: 602–608.
71. Lench N, Barrett A, Fielding S, McKay F, Hill M, Jenkins L, White H, Chitty LS. 2013. The clinical implementation of non-invasive prenatal diagnosis for single-gene disorders: Challenges and progress made. Prenat Diagn 33: 555–562.
72. Lewis C, Silcock C, Chitty LS. 2013. Non-invasive prenatal testing for Down’s syndrome: Pregnant women’s views and likely uptake. Public Health Genomics 16: 223–232.
73. Lewis C, Hill M, Silcock C, Daley R, Chitty LS. 2014a. Noninvasive prenatal testing for trisomy 21: A cross-sectional survey of service users’ views and likely uptake. BJOG 121: 582–594.
74. Lewis C, Choudhury M, Chitty LS. 2014b. ‘Hope for safe prenatal gene tests’. A content analysis of how the UK press media are reporting advances in non-invasive prenatal testing. Prenat Diagn doi: 10.1002/pd.4488.
75. Lo YMD, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CWG. 1997. Presence of fetal DNA in maternal plasma and serum. Lancet 350: 485–487.
76. Lo YMD, Hjelm NM, Fidler C, Sargent IL, Murphy MF, Chamberlain PF, Poon PM, Redman CW, Wainscoat JS. 1998a. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl JMed 339: 1734–1738.
77. LoY MD, Tein MS, Lau TK, Haines CJ, Leung TN, Poon PM, Wainscoat JS, Johnson PJ, Chang AM, Hjelm NM. 1998b. Quantitative analysis of fetal DNA in maternal plasma and serum: Implications for non-invasive prenatal diagnosis. Am J Hum Genet 62: 768–775.
78. Lo YMD, Lau TK, Zhang J, Leung TN, Chang AM, Hjelm NM, Elmes RS, Bianchi DW. 1999a. Increased fetal DNA concentrations in the plasma of pregnant women carrying fetuses with trisomy 21. Clin Chem 45: 1747–1751.
79. Lo YMD, Zhang J, Leung TN, Lau TK, Chang AM, Hjelm NM. 1999b. Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet 64: 218–224.
80. Lo YMD, Tsui NB, Chiu RW, Lau TK, Leung TN, Heung MM, Gerovassili A, Jin Y, Nicolaides KH, Cantor CR, et al. 2007a. Plasma placental RNA allelic ratio permits non-invasive prenatal chromosomal aneuploidy detection. Nat Med 13: 218–223.
81. Lo YMD, Lun FMF, Chan KCA, Tsui NBY, Chong KC, Lau TK, Leung TY, Zee BCY, Cantor CR, Chiu RWK. 2007b. Digital PCR for the molecular detection of fetal chromosomal aneuploidy. Proc Natl Acad Sci 104: 13116–13121.
82. Lo YMD, Chan KC, Sun H, Chen EZ, Jiang P, Lun FM, Zheng YW, Leung TY, Lau TK, Cantor CR, et al. 2010. Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med 2: 61-91.
83. Lun FM, Tsui NB, Chan KC, Leung TY, Lau TK, Charoenkwan P, Chow KC, Lo WY, Wanapirak C, Sanguansermsri T, et al. 2008a. Non-invasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma. Proc Natl Acad Sci 105: 19920–19925.
84. Lun FM, Chiu RW, Allen Chan KC, Yeung Leung T, Kin Lau T, Lo YMD. 2008b. Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma. Clin Chem 54: 1664–1672.
85. Lun FM, Chiu RW, Sun K, Leung TY, Jiang P, Chan KC, Sun H, Lo YMD. 2013. Non-invasive prenatal methylomic analysis by genome-wide bisulfite sequencing of maternal plasma DNA. Clin Chem 59: 1583–1594.
86. Ma D, Ge H, Li X, Jiang T, Chen F, Zhang Y, Hu P, Chen S, Zhang J, Ji X, et al. 2014. Haplotype-based approach for non-invasive prenatal diagnosis of congenital adrenal hyperplasia by maternal plasma DNA sequencing. Gene 544: 252–258.
87. Mazloom AR, Dzakula Z, Oeth P, Wang H, Jensen T, Tynan J, McCullough R, Saldivar JS, Ehrich M, van den Boom D, et al. 2013. Non-invasive prenatal detection of sex chromosomal aneuploidies by sequencing circulating cell-free DNA from maternal plasma. Prenat Diagn 33: 591–597.
88. McCullough RM, Almasri EA, Guan X, Geis JA, Hicks SC, Mazloom AR, Deciu C, Oeth P, Bombard AT, Paxton B, et al. 2014. Non-invasive prenatal chromosomal aneuploidy testing - clinical experience: 100,000 clinical samples. PLoS ONE 9: e109173.
89. Michaelson-Cohen R, Gershoni-Baruch R, Sharoni R, Shochat M, Yaron Y, Singer A. 2014. Israeli Society ofMedical Genetics NIPT Committee Opinion 072013: Non-invasive prenatal testing of cell-free DNA in maternal plasma for detection of fetal aneuploidy. Fetal Diagn Ther 36: 242–244.
90. Morris S, Karlsen S, Chung N, Hill M, Chitty LS. 2014. Model-based analysis of costs and outcomes of non-invasive prenatal testing for Down’s syndrome using cell free fetal DNA in the UK National Health Service. PLoS ONE 9: e93559.
91. Musci TJ, Fairbrother G, Batey A, Bruursema J, Struble C, Song K. 2013.Non-invasive prenatal testing with cell-free DNA: US physician attitudes toward implementation in clinical practice. Prenat Diagn 33: 424–428.
92. New MI, Tong YK, Yuen T, Jiang P, Pina C, Chan KC, Khattab A, Liao GJ, Yau M, Kim SM, et al. 2014. Non-invasive prenatal diagnosis of congenital adrenal hyperplasia using cell-free fetal DNA in maternal plasma. J Clin Endocrinol Metab 99: 1022–1030.
93. Nicolaides KH, Syngelaki A, del Mar Gil M, Quezada MS, Zinevich Y. 2014. Prenatal detection of fetal triploidy fromcell-freeDNAtesting in maternal blood. Fetal Diagn Ther 35: 212–217.
94. Nizard J, Duyme M, Ville Y. 2002. Teaching ultrasoundguided invasive procedures in fetal medicine: Learning curves with and without an electronic guidance system. Ultrasound Obstet Gynecol 19: 274–277.
95. Norton ME, Brar H, Weiss J, Karimi A, Laurent LC, Caughey AB, Rodriguez MH, Williams J III, Mitchell ME, Adair CD, et al. 2012. Non-Invasive Chromosomal Evaluation (NICE) Study: Results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol 207: 131–138.
96. Norton ME, Jacobsson B, Swamy G, Laurent LC, Ranzini A, Brar H, Tomlinson M, Pereira L, Spitz J, Holleman D, et al. 2014. Non-invasive examination of trisomy using directed cell-free DNA analysis. The NEXT study. Prenat Diagn 34: e2.
97. Ohno M, Caughey A. 2013. The role of non-invasive prenatal testing as a diagnostic versus a screening tool—A costeffectiveness analysis. Prenat Diagn 33: 630–635.
98. Osborne CM, Hardisty E, Devers P, Kaiser-Rogers K, Hayden MA, Goodnight W, Vora NL. 2013. Discordant noninvasive prenatal testing results in a patient subsequently diagnosed with metastatic disease. Prenat Diagn 33: 609–611.
99. Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, Ehrich M, van den Boom D, Bombard AT, Deciu C, Grody WW, et al. 2011. DNA sequencing of maternal plasma to detect Down syndrome: An international clinical validation study. Genet Med 13: 913–920.
100. Palomaki GE, Deciu C, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, Ehrich M, van den Boom D, Bombard AT, Grody WW, et al. 2012. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: An international collaborative study. Genet Med 14: 296–305.
101. Pan M, Li FT, Li Y, Jiang FM, Li DZ, Lau TK, Liao C. 2013. Discordant results between fetal karyotyping and noninvasive prenatal testing by maternal plasma sequencing in a case of uniparental disomy 21 due to trisomic rescue. Prenat Diagn 33: 598–601.
102. Peters D, Chu T, Yatsenko SA, Hendrix N, Hogge WA, Surti U, Bunce K, Dunkel M, Shaw P, Rajkovic A. 2011. Noninvasive prenatal diagnosis of a fetal microdeletion syndrome. N Engl J Med 365: 1847–1848.
103. Poon LC, Nicolaides K. 2014. First-trimester maternal factors and biomarker screening for pre-eclampsia. Prenat Diagn 34: 618–627.
104. Poon LLM, Leung TN, Lau TK, Lo YMD. 2000. Presence of fetalRNA in maternal plasma. Clin Chem 46: 1832–1834.
105. Poon LL, Leung TN, Lau TK, Chow KC, Lo YM. 2002. Differential DNA methylation between fetus and mother as a strategy for detecting fetal DNA in maternal plasma. Clin Chem 48: 35–41.
106. Rabinowitz M, Savage M, Pettersen B, Sigurjonsson S, Hill M, Zimmermann B. 2014. Non-invasive cell-free DNAbased prenatal detection of microdeletions using single nucleotide polymorphism-targeted sequencing. Obstet Gynecol 123: 167S.
107. Rose NC, Lagrave D, Hafen B, Jackson M. 2013. The impact of utilization of early aneuploidy screening on amniocenteses available for training in obstetrics and fetal medicine. Prenat Diagn 33: 242–244.
108. Saito H, Sekizawa A, Morimoto T, Suzuki M, Yanaihara T. 2000. Prenatal DNA diagnosis of a single-gene disorder from maternal plasma. Lancet 356: 1170.
109. Sanderson S, Zimmern R, Kroese M, Higgins J, Patch C, Emery J. 2005. How can the evaluation of genetic tests be enhanced? Lessons learned from the ACCE framework and evaluating genetic tests in the United Kingdom. Genet Med 7: 495–500.
110. Sayres LC, Allyse M, Norton ME, Cho MK. 2011. Cell-free fetal DNA testing: A pilot study of obstetric healthcare provider attitudes toward clinical implementation. Prenat Diagn 31: 1070–1076.
111. Sehnert AJ, Rhees B, Comstock D, de Feo E, Heilek G, Burke J, Rava RP. 2011. Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood. Clin Chem 57: 1042–1049.
112. Sparks AB, Struble CA, Wang ET, Song K, Oliphant A. 2012a. Non-invasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: Evaluation for trisomy 21 and trisomy 18. Am J Obstet Gynecol 206: 311–319.
113. Sparks AB, Wang ET, Struble CA, Barrett W, Stokowski R, McBride C, Zahn J, Lee K, Shen N, Doshi J, et al. 2012b. Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy. Prenat Diagn 32: 3–9.
114. Srinivasan A, Bianchi DW, Huang H, Sehnert AJ, Rava RP. 2013. Non-invasive detection of fetal subchromosome abnormalities via deep sequencing of maternal plasma. Am J Hum Genet 92: 167–176.
115. Tischler R, Hudgins L, Blumenfeld YJ, Greely HT, Ormond KE. 2011. Non-invasive prenatal diagnosis: Pregnant women’s interest and expected uptake. Prenat Diagn 31: 1292–1299.
116. Tong YK, Ding C, Chiu RWK, Gerovassili A, Chim SSC, Leung TY, Leung TN, Lau TK, Nicolaides KH, Lo YMD. 2006. Non-invasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: Theoretical and empirical considerations. Clin Chem 52: 2194–2202.
117. Tsui NB, Kadir RA, Chan KC, Chi C, Mellars G, Tuddenham EG, Leung TY, Lau TK, Chiu RW, Lo YMD. 2011. Noninvasive prenatal diagnosis of hemophilia by microfluidics digital PCR analysis of maternal plasma DNA. Blood 117: 3684–3691.
118. Tsui NBY, Jiang P, Wong YF, Leung TY, Chan KC, Chiu RW, Sun H, Lo YMD. 2014.Maternal plasmaRNA sequencing for genome-wide transcriptomic profiling and identification of pregnancy-associated transcripts. Clin Chem 60: 954–962.
119. Vahanian SA, Baraa Allaf M, Yeh C, Chavez MR, Kinzler WL, Vintzileos Am. 2014. Patient acceptance of non-invasive testing for fetal aneuploidy via cell-free fetal DNA. J Matern Fetal Neonatal Med 27: 106–109.
120. Verweij EJ, Jacobsson B, van Scheltema PA, de Boer MA, Hoffer MJ, Hollemon D, Westren M, Song K, Oepkes D. 2013. European non-invasive trisomy evaluation (EU-NITE) study: A multicenter prospective cohort study for non-invasive fetal trisomy 21 testing. Prenat Diagn 33: 996–1001.
121. Wang Y, Chen Y, Tian F, Zhang J, Song Z, Wu Y, Han X, Hu W, Ma D, Cram D, et al. 2014a. Maternal mosaicism is a significant contributor to discordant sex chromosomal aneuploidies associated with non-invasive prenatal testing. Clin Chem 60: 251–259.
122. Wang JC, Sahoo T, Schonberg S, Kopita KA, Ross L, Patek K, StromCM. 2014b. Discordant non-invasive prenatal testing and cytogenetic results: A study of 109 consecutive cases. Genet Med doi: 10.1038/gim.2014.92.
123. Yao H, Jiang F, Hu H, Gao Y, Zhu Z, Zhang H, Wang Y, Guo Y, Liu L, Yuan Y, et al. 2014. Detection of fetal sex chromosome aneuploidy by massively parallel sequencing of maternal plasma DNA: Initial experience in a Chinese hospital. Ultrasound Obstet Gynecol 44: 17–24.
124. Yu SCY, Jiang P, Choy KW, Chan KC, Won HS, Leung WC, Lau ET, Tang MH, Leung TY, Lo YMD, et al. 2013. Noninvasive prenatal molecular karyotyping from maternal plasma. PLoS ONE 8: e60968.
125. Yu SCY, Chan KC, Zheng YW, Jiang P, Liao GJ, Sun H, Akolekar R, Leung TY, Go AT, van Vugt JM, et al. 2014. Size-based molecular diagnostics using plasma DNA for non-invasive prenatal testing. Proc Natl Acad Sci 111: 8583–8588.
126. Zimmermann B, Hill M, Gemelos G, Demko Z, Banjevic M, Baner J, Ryan A, Sigurjonsson S, Chopra N, Dodd M, et al. 2012. Non-invasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphic loci. Prenat Diagn 32: 1233–1241.